You must login before you can post a comment.
St. Pancras Renaissance Hotel London
Registration
With Brexit being the hot topic of discussion for the global citizen, the international pharma and biotech sector in the UK and EU are engaged in a deep dialogue about the possible ramifications.
Prof. Dr. Jochen Maas, General Manager R&D, Sanofi-Aventis & other branch experts will discuss new solutions for regulatory issues, certification as well as recruiting and trading on 10th September.
The event is free to attend, but places are limited, and will be allocated on a first come, first served basis.
AGENDA
5.30 pm Registration
6.00 pm Welcome remarks & Keynote speech
Prof. Dr. Jochen Maas, General Manager R&D, Sanofi-Aventis Deutschland GmbH
Eric Menges, President and CEO of FrankfurtRheinMain GmbH
6.15 pm Panel discussion and Q&A
Dr. Christian Garbe, Managing Director, The FiZ Frankfurt Biotechnology Innovation Center
Prof. Dr. Bertram Häussler, Chairman of the Board of Management, the IGES Institute, one of Germany’s largest healthcare research institutes
Dr. Paul Ingram, Global Director, Strategic Development and Innovation, Clinical Supply Services, Catalent Pharma Solutions
Dr. Elmar Kroth, Managing Director Scientific Affairs, the German Medicines Manufacturers´ Association
Prof. Dr. Jochen Maas, General Manager R & D, Sanofi-Aventis Deutschland GmbH
7.15 pm End of the panel discussion
This forum is designed to provoke a lively discussion and debate as well as provide information and guidance.
The Panel Discussion will be followed by a networking reception and cocktail buffet.